RxDoctor Payments Data

Troy Woodman, MD

Plastic Surgery Within the Head and Neck · Tacoma, WANPI 1487638086

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Amgen at 48.6% of the total. Reporting peaked in 2023 at $573 and has fallen 86.9% since, to $75 in 2025. That places this record below the midpoint for plastic surgery within the head and neck clinicians in WA, where the typical reported total is $2,309.

$1,972in general payments, 2019–2025

Across 72 payments — averaging $27.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$958
  • AbbVie$856
  • Baxter Healthcare$86
  • Oyster Point Pharma, Inc.$28
  • Galderma Laboratories, L.p.$17
  • Merck$14
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$1,972100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)20$958
AbbVie(2 entities)44$856
Baxter Healthcare4$86
Oyster Point Pharma, Inc.1$28
Galderma Laboratories, L.p.1$17
Merck1$14
Smith+Nephew1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,972 in reported general payments places this provider in the 45th percentile of 21 plastic surgery within the head and neck providers in Washington.

See all plastic surgery within the head and neck providers in Washington

Medicare billing

Part B allowed, 2024
$372,871
Medicare patients
363
Services billed
7,107

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ErythromycinErythromycin Base315$3,334
Loteprednol Etabonate13$2,023
Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha146$1,611
Cephalexin82$1,590
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen263$756
Methylprednisolone87$588
Clobetasol Propionate21$464
Ondansetron OdtOndansetron49$245
Scopolamine15$207
Oxycodone Hcl58$177
Acyclovir40$175
Fluticasone Propionate13$141

Paid to pharmacies, not to this prescriber.

Other plastic surgery within the head and neck in Tacoma

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →